戻る Agenda
Session # 1- Regulatory Trends in Clinical Safety & Pharmacovigilance
Session Chair(s)
J Vijay Venkatraman, MD, MBA
Managing Director and CEO
Oviya Medsafe Pvt Ltd, India
Speaker(s)
Mangesh Kulkarni, MD
Tata Consultancy Services, India
Global Head – Drug Safety
Brexit and Its Pharmacovigilance After Effects
Seema Jaitly, DrMed
Sagittal Pharma Consulting Ltd, United Kingdom
Managing Director
Resolving the R3 Tangle
Punit Wason
High Point Solutions, An IQVIA Company, India
Sr. Manager